AlphaCore Capital’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
11,733
+2,481
+27% +$349K 0.03% 347
2026
Q1
$1.21M Buy
9,252
+716
+8% +$103K 0.03% 337
2025
Q4
$1.13M Buy
8,536
+475
+6% +$63K 0.03% 391
2025
Q3
$1.06M Buy
8,061
+1,279
+19% +$174K 0.04% 289
2025
Q2
$904K Sell
6,782
-113
-2% -$13K 0.03% 272
2025
Q1
$756K Buy
6,895
+1,727
+33% +$208K 0.06% 204
2024
Q4
$640K Sell
5,168
-57
-1% -$6.91K 0.14% 104
2024
Q3
$571K Sell
5,225
-24
-0.5% -$2.58K 0.13% 103
2024
Q2
$578K Buy
5,249
+35
+0.7% +$3.87K 0.14% 96
2024
Q1
$591K Buy
5,214
+51
+1% +$5.24K 0.16% 86
2023
Q4
$503K Sell
5,163
-1
-0% -$92 0.07% 142
2023
Q3
$499K Buy
5,164
+493
+11% +$47K 0.08% 146
2023
Q2
$422K Buy
4,671
+200
+4% +$16.8K 0.07% 153
2023
Q1
$390K Sell
4,471
-70
-2% -$6.12K 0.1% 94
2022
Q4
$436K Buy
4,541
+300
+7% +$27K 0.17% 51
2022
Q3
$311K Buy
4,241
+1,561
+58% +$130K 0.14% 51
2022
Q2
$213K Buy
2,680
+600
+29% +$52.9K 0.1% 66
2022
Q1
$204K Buy
+2,080
New +$197K 0.08% 72

Other funds holding EMR

AlphaCore Capital's EMR Position: Q2 2026 in Review

AlphaCore Capital increased its Emerson Electric (EMR) stake by 27% in Q2 2026, buying an estimated $349K and bringing the position to 11,733 shares worth $1.68M. The position accounts for 0.03% of the portfolio, ranked #347.

AlphaCore Capital first reported a position in EMR in Q1 2022 and has held it in 18 quarters since. 2,284 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

  • AlphaCore Capital held 11,733 shares of Emerson Electric worth $1.68M as of Q2 2026.
  • AlphaCore Capital bought 2,481 Emerson Electric shares in Q2 2026, an estimated $349K.
  • Emerson Electric made up 0.03% of AlphaCore Capital's portfolio in Q2 2026, its #347 holding.
  • AlphaCore Capital first reported a position in Emerson Electric in Q1 2022 and has held it in 18 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.